Zealand Pharma A/S (ZEAL) 2022年CSR报告「NASDAQ」.pdf

《Zealand Pharma A/S (ZEAL) 2022年CSR报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《Zealand Pharma A/S (ZEAL) 2022年CSR报告「NASDAQ」.pdf（17页珍藏版）》请在三个皮匠报告上搜索。

1、Company reg.no.20045078Corporate Responsibility Report 2022ContentsCorporate Social Responsibility Report 2022Our responsibility 3Changing lives 4Transforming peptides 5Our business model 6Our focus 7Our people 8Quality 11Patients 12Environment 14Ethics 15About this ReportThis statutory report on co

2、rporate social and environmental responsibility is for the financial year 2022,cf.section 99a and 99b of the Danish Financial Statements Act.This report is a supplement to the managements review in the Annual Report 2022 covering the period January 1 to December 31,2022.2Zealand Pharma Corporate Res

3、ponsibility Report 2022Our responsibilityFind out more about Zealand at Zealand Pharmas Board,Management,and employees recognize that we,as a company within the wider commu-nity,have a responsibility to society and the environment.As a small,but growing,company,we believe in sharing this responsibil

4、ity.We are aligned with investors and other stakeholders,who are increasingly focused on social and environmental issues beyond just legal obligations.And our employees are highly engaged in this aspect of the companys performance,providing a continuous source of inspiration and ideas for improvemen

5、t.Our responsibility encompasses:Supporting the health,engagement and development of our employees who are the key to our continued success Aiming to improve the lives of patients with unmet needs by engaging with a broad range of stakeholders(patient advocacy groups,thought leaders and external exp

6、erts,governments,hospitals,prescribers,and payors)Ensuring that we conduct business to the highest standards Acting to reduce our impact on the environmentAs a biotech company we are focused on developing new medicines to address serious medical needs and improve human health,but we also focused on